The store will not work correctly when cookies are disabled.
US9242982, 1i
ID: ALA3979496
PubChem CID: 77846498
Max Phase: Preclinical
Molecular Formula: C16H14BrN3O3
Molecular Weight: 376.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1c(=O)c2cc(Cc3ccccc3Br)c(=O)[nH]c2n(C)c1=O
Standard InChI: InChI=1S/C16H14BrN3O3/c1-19-13-11(15(22)20(2)16(19)23)8-10(14(21)18-13)7-9-5-3-4-6-12(9)17/h3-6,8H,7H2,1-2H3,(H,18,21)
Standard InChI Key: TVATZXQYBGYNLS-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 2.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1953 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1932 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8915 -3.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8863 -5.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1828 -6.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4844 -5.2585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4896 -3.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5309 -3.1621 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9364 1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
3 5 1 0
5 6 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
17 18 1 0
10 19 1 0
19 20 2 0
19 21 1 0
21 7 1 0
8 22 1 0
22 2 1 0
22 23 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 376.21 | Molecular Weight (Monoisotopic): 375.0219 | AlogP: 1.28 | #Rotatable Bonds: 2 |
Polar Surface Area: 76.86 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.88 | CX Basic pKa: ┄ | CX LogP: 1.84 | CX LogD: 1.83 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.73 | Np Likeness Score: -0.73 |
References
1. (2016) Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof, |